Related references
Note: Only part of the references are listed.Physical Fitness and Chemotherapy Tolerance in Patients with Early-Stage Breast Cancer
Wim G. Groen et al.
MEDICINE & SCIENCE IN SPORTS & EXERCISE (2022)
Cost evaluation of an exercise oncology intervention: The exercise in all chemotherapy trial
Melanie Potiaumpai et al.
CANCER REPORTS (2022)
Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: a systematic review
Dominic O'Connor et al.
BMC CANCER (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The exercise in all chemotherapy trial
Kathryn H. Schmitz et al.
CANCER (2021)
Exercise and health-related fitness predictors of chemotherapy completion in breast cancer patients: pooled analysis of two multicenter trials
Ki-Yong An et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial
Sara Mijwel et al.
ONCOLOGIST (2020)
Supervised, Multimodal Exercise: The Chemotherapy Supportive Therapy That Almost Does It All
Amy A. Kirkham
ONCOLOGIST (2020)
The effect of reduced RDI of chemotherapy on the outcome of breast cancer patients
Wanwan Qi et al.
SCIENTIFIC REPORTS (2020)
Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: A systematic review
Doris L. van Abbema et al.
JOURNAL OF GERIATRIC ONCOLOGY (2019)
Influence of initial dose intensity on efficacy of FOLFIRINOX in patients with advanced pancreatic cancer
Satoshi Kobayashi et al.
Oncotarget (2019)
Impact of exercise on chemotherapy completion rate: A systematic review of the evidence and recommendations for future exercise oncology research
Kelcey A. Bland et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Recruitment to and pilot results of the PACES randomized trial of physical exercise during adjuvant chemotherapy for colon cancer
Hanna van Waart et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2018)
Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I-III breast cancer: ER+/PR+, HER2-vs. triple-negative
Lu Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study
Ana Fernandez et al.
BMC CANCER (2018)
The relationship between antitumor effects and relative dose intensity of gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer.
Kazunaga Ishigaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Effects of an Exercise Program in Colon Cancer Patients undergoing Chemotherapy
Jonna K. Van Vulpen et al.
MEDICINE & SCIENCE IN SPORTS & EXERCISE (2016)
Cancer survivorship: long-term side-effects of anticancer treatments of gastrointestinal cancer
Gianmauro Numico et al.
CURRENT OPINION IN ONCOLOGY (2015)
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices
Neelima Denduluri et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Effects of Exercise Dose and Type During Breast Cancer Chemotherapy: Multicenter Randomized Trial
Kerry S. Courneya et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice
Derek Weycker et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Impact of Chemotherapy Dose Intensity on Cancer Patient Outcomes
Gary H. Lyman
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
Prevalence of outpatient cancer treatment in the United States: Estimates from the Medical Panel Expenditures Survey (MEPS)
Michael T. Halpern et al.
CANCER INVESTIGATION (2008)
Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: A multicenter randomized controlled trial
Kerry S. Courneya et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)